This site requires Javascript.

Please enable Javascript before proceeding:

Firefox

  1. In the FireFox address bar, type about:config.
  2. Look for the javascript.enabled setting.
  3. Set it to true by right-clicking and pressing toggle.

Internet Explorer

  1. On the Tools menu, click Internet Options, then click the Security tab.
  2. Click the Internet Zone.
  3. If you do not have to customize your Internet security settings, click Default Level. Then do step 4.
  4. If you have to customize your Internet security settings, follow these steps:
    a. Click Custom Level.
    b. In the Security Settings - Internet Zone dialog box, click Enable for Active Scripting in the Scripting section.
  5. Click the Back button to return to the previous page, and then click the Refresh button to run scripts.

Chrome

  1. In the Chrome address bar, type chrome://settings/content/javascript.
  2. Adjust the toggle so that javascript is allowed.
  3. Close the Settings tab and Refresh the page.

 

This program has received financial support in the way of an educational grant from:

Kam Jorge
jkam01@amgen.com
647-241-3735
www.amgen.ca

CLINICAL EFFICACY AND SAFETY OF ACHIEVING VERY LOW LDL-CHOLESTEROL CONCENTRATIONS WITH THE PCSK9 INHIBITOR EVOLOCUMAB
CLICK TO VIEW / DOWNLOAD

EFFECT OF EVOLOCUMAB ON PROGRESSION OF CORONARY DISEASE IN STATIN-TREATED PATIENTS
CLICK TO VIEW / DOWNLOAD

EVOLOCUMAB AND CLINICAL OUTCOMES IN PATIENTS WITH CARDIOVASCULAR DISEASE
CLICK TO VIEW / DOWNLOAD

Find your Medical Sales Representative:

salesrep.info@astrazeneca.com

Medical Information Inquiries & Adverse Event Reporting:

Ask-medical@astrazeneca.com

1-877-404-8277 (toll-free)

https://www.astrazeneca.ca/en



David Hamel
david.hamel@bayer.com
514-603-6637
www.bayer.com

Kristin Muxlow
kristin.muxlow@boehringer-ingelheim.com
705-715-3438
www.boehringer-ingelheim.ca

SELECT NON-INSULIN TREATMENTS FOR TYPE 2 DIABETES
CLICK TO VIEW / DOWNLOAD

SAD MANS BROCHURE
CLICK TO VIEW / DOWNLOAD

TYPE 2 DIABETES RISK FACTORS AND COMPLICATIONS
CLICK TO VIEW / DOWNLOAD

\

Don Morrison
d.morrison@hlstherapeutics.com
289-259-3609
https://www.vascepa.ca/en

Janssen Medical Information
medinfocanada@its.jnj.com
1-800-567-331
www.janssenmedicalinformation.ca

NEJM: CANAGLIFLOZIN AND RENAL OUTCOMES IN TYPE 2 DIABETES AND NEPHROPATHY
CLICK TO VIEW / DOWNLOAD


www.novartis.ca

2021 CCS HF GUIDELINES
CLICK TO VIEW / DOWNLOAD

ENTRESTO PROUCT MONOGRAPH
CLICK TO VIEW / DOWNLOAD

LEQVIO PRODUCT MONOGRAPH
CLICK TO VIEW / DOWNLOAD